WHO halts hydroxychloroquine trials after failure to reduce death | Off-Topic Political Arena Message Board Posts
Off-Topic Political Arena

Off-Topic Political Arena   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  297910 of 299678  at  7/4/2020 8:46:16 PM  by

nopec2001


WHO halts hydroxychloroquine trials after failure to reduce death

https://www.msn.com/en-us/news/world/who-halts-hydroxychloroquine-trials-after-failure-to-reduce-death/ar-BB16l2Ba

The World Health Organization (WHO) announced Saturday it is halting its trials of the malaria drug hydroxychloroquine and HIV treatment lopinavir/ritonavir in patients hospitalized with the coronavirus after results showed the drugs did not reduce mortality rates."These interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalized COVID-19 patients when compared to standard of care. Solidarity trial investigators will interrupt the trials with immediate effect," the WHO said in a statement, referencing multi-country trials it is conducting.

The group, a United Nations agency, said it was ending the tests on the recommendation of the drug trial's international steering committee. The pause does not impact other studies in which the drugs are used for patients who are not hospitalized.

The WHO is also examining the potential effect of remdesivir, an anti-viral drug from Gilead, on COVID-19.

The WHO's announcement comes two days after a study was released linking the use of hydroxychloroquine by COVID-19 patients to lower death rates.

In patients who received the drug, the death rate was 13 percent as compared to a death rate of 26.4 percent in patients who weren't administered the treatment.

Studies have offered at scattershot assessment of hydroxychloroquine's effectiveness in battling the coronavirus. The Food and Drug Administration earlier this year yanked the drug's emergency use authorization, citing data from a large randomized controlled trial that showed no difference between using hydroxychloroquine and standard COVID-19 treatment.
 

President Trump had emerged as a chief cheerleader for the drug, at one point even saying he was taking it himself as a preventative measure.

 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 25
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
297970 Re: WHO halts hydroxychloroquine trials after failure to reduce death sirg 3 7/6/2020 9:24:54 AM






Financial Market Data provided by
.


Loading...